Log In
BCIQ
Print this Print this
 

AB42 vaccine (NU 700)

  Manage Alerts
Collapse Summary General Information
Company Vitruvian Biomedical Inc.
DescriptionDNA vaccine containing a gene fragment coding for beta amyloid 42
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat and prevent Alzheimer's disease (AD)
Regulatory Designation
PartnerNuron Biotech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/16/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today